B cell receptor signaling in autoimmune rheumatic diseases: regulatory mechanisms and therapeutic targeting

Autoimmune rheumatic diseases (ARDs) are a diverse group of chronic disorders characterized by immune dysregulation and multi-organ inflammation. B cell receptor (BCR) signaling emerges as a shared, yet heterogeneously regulated, pathogenic axis across these diseases. This dysre…

Criar conta gratuita para acessar o conteúdo completo